Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse events of anti-PD-1 antibody for breast cancer.
联合靶向 CDK4/6 可增强抗癌活性，并减轻抗 PD-1 抗体治疗乳腺癌引起的免疫相关不良反应。
期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102429
Hu Shu-Wei, Yeh Ming-Hsin, He Yu-Hao, Wei Ya-Ling, Cheng Fang-Ju, Yeh Yi-Lun, Huynh Thanh Kieu, Liu Pei-Tong, Hu Dai-Wei, Chang Tzu-Hsuan, Wang Bo-Wei, Chen Bo-Rong, Lin Mei-Chun, Lee Der-Yen, Hsieh Yi-Hsien, Hsu Yuan-Man, Tang Chih-Hsin, Ho Ping-Chih, Hung Mien-Chie, Huang Wei-Chien
